Skip to main content
. 2013 Jan 11;8(1):e53519. doi: 10.1371/journal.pone.0053519

Figure 2. Serum markers related to liver damage in CHC patients.

Figure 2

a) fibrosis, b) hepatitis and c) steatosis severity. Fibrosis stages according METAVIR. Significant fibrosis (F≥2) and advanced fibrosis (F≥3). * p<0.05;·# trend of association p<0.08.